DUBLIN--(BUSINESS WIRE)--The "Sepsis Diagnostic Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
The study includes the sepsis diagnostic market size and forecast for the global sepsis diagnostic market through 2024, segmented by technology, product, pathogen, test type, end user, and region.
The future of the sepsis diagnostic market looks promising with opportunities in the hospitals, and pathology, and reference laboratories. The major growth drivers for this market are increasing geriatric population, development of drug-resistance among individuals, and high incidence of hospital-acquired infection, and an increasing number of surgical procedures.
Some of the sepsis diagnostics companies profiled in this report include Biomerieux, T2 Biosystems, Luminex, Becton Dickinson (BD), Roche Diagnostics, Danaher, Thermo Fisher Scientific, Bruker, Abbott, Immunexpress, Response Biomedical, Axis-Shield Diagnostics, Cytosorbents, Mitsubishi Chemical, and EKF Diagnostics.
Some of the features of 'Global Sepsis Diagnostic market 2019-2024: Trends, Forecast, and Opportunity Analysis' include:
- Market size estimates: Global sepsis diagnostic market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis: Global market size by technology, product, pathogen, test type, end user, and region.
- Regional analysis: Global sepsis diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities: Analysis on growth opportunities in different applications and regions for sepsis diagnostics in the global sepsis diagnostic market.
- Strategic analysis: This includes M&A, new product development, and competitive landscape for, sepsis diagnostics in the global sepsis diagnostic market.
- Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers the following 11 key questions:
- What are some of the most promising potential, high-growth opportunities for the global sepsis diagnostic market?
- Which segments will grow at a faster pace and why?
- Which regions will grow at a faster pace and why?
- What are the key factors affecting market dynamics? What are the drivers and challenges of the sepsis diagnostic market?
- What are the business risks and threats to the sepsis diagnostic market?
- What are emerging trends in this sepsis diagnostic market and the reasons behind them?
- What are some changing demands of customers in the sepsis diagnostic market?
- What are the new developments in the sepsis diagnostic market? Which companies are leading these developments?
- Who are the major players in this sepsis diagnostic market? What strategic initiatives are being implemented by key players for business growth?
- What are some of the competitive products and processes in this sepsis diagnostics area and how big of a threat do they pose for loss of market share via material or product substitution?
- What M & A activities have taken place in the last 5 years in sepsis diagnostic market?
Key Topics Covered:
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2013 to 2024
3.1: Macroeconomic Trends and Forecast
3.2: Global Sepsis Diagnostic Market: Trends and Forecast
3.3: Global Sepsis Diagnostic Market by Technology
3.3.1: Microbiology
3.3.2: Molecular Diagnostic
3.3.3: Immunoassays
3.3.4: Flow Cytometry
3.3.5: Microfluidics
3.3.6: Biomarkers
3.4: Global Sepsis Diagnostic Market by Product
3.4.1: Blood Culture Media
3.4.2: Assays & Reagents
3.4.3: Instruments
3.4.4: Software
3.5: Global Sepsis Diagnostic Market by Pathogen
3.5.1: Bacterial Sepsis
3.5.2: Fungal Sepsis
3.5.3: Other Pathogens
3.6: Global Sepsis Diagnostic Market by Test Type
3.6.1: Laboratory Tests
3.6.2: Point-of-care Tests
3.7: Global Sepsis Diagnostic Market by End User
3.7.1: Hospitals
3.7.2: Pathology & Reference Laboratories
4. Market Trends and Forecast Analysis by Region
4.1: Global Sepsis Diagnostic Market by Region
4.2: North American Sepsis Diagnostic Market
4.2.1: Market by Technology: Microbiology, Molecular Diagnostic, Immunoassays, Flow Cytometry, Microfluidics, and Biomarkers
4.2.2: Market by Product: Blood Culture Media, Assays & Reagents, Instruments, and Software
4.2.3: Market by Pathogen: Bacterial Sepsis, Fungal Sepsis, and Other Pathogens
4.2.4: Market by Test Type: Laboratory Tests and Point-of-care Tests
4.2.5: Market by End User: Hospitals and Pathology & Reference Laboratories
4.3: European Sepsis Diagnostic Market
4.4: APAC Sepsis Diagnostic Market
4.5: ROW Sepsis Diagnostic Market
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for Global Sepsis Diagnostic Market by Technology
6.1.2: Growth Opportunities for Global Sepsis Diagnostic Market by Product
6.1.3: Growth Opportunities for Global Sepsis Diagnostic Market by Pathogen
6.1.4: Growth Opportunities for Global Sepsis Diagnostic Market by Test Type
6.1.5: Growth Opportunities for Global Sepsis Diagnostic Market by End User
6.1.6: Growth Opportunities for Global Sepsis Diagnostic Market by Region
6.2: Emerging Trends in Global Sepsis Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of Global Sepsis Diagnostic Market
6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Sepsis Diagnostic Market
7. Company Profiles of Leading Players
- Biomerieux
- T2 Biosystems
- Luminex
- Becton Dickinson (BD)
- Roche Diagnostics
- Danaher
- Thermo Fisher Scientific
- Bruker
- Abbott
- Immunexpress
For more information about this report visit https://www.researchandmarkets.com/r/s1pbhu
